Javascript must be enabled to continue!
The Effects of Pharmacological Interventions on Smoking Cessation in People with Alcohol Dependence: A Systematic Review and Meta-analysis of Nine Randomized Controlled Trials
View through CrossRef
Background Pharmacotherapies are widely used for smoking cessation.
However, their effect on smoking cessation for people with alcohol
dependence remains unclear. Objective This study aimed to explore the
effects of pharmacotherapies on smoking cessation for people with
alcohol dependence. Methods Five electronic databases were searched in
January 2021 for randomized controlled trials (RCTs) reporting the use
of pharmacotherapies to promote smoking cessation in people with alcohol
dependence. The risk of bias was assessed using the Cochrane tool.
RevMan version 5.3 was used to perform meta-analyses of the changes in
smoking behavior, and the GRADE approach was used to assess the
certainty of the evidence. Results Nine RCTs involving 908 smokers with
alcohol dependence were identified. Eight RCTs were published in the
United States, and one was from Canada. The risk of bias was rated as
low in three studies and unclear in the remaining six. The results of
the meta-analysis showed that, compared with the placebo group,
Varenicline had a significant effect on short-term smoking cessation
(three RCTs, OR = 6.27, 95% CI: [2.49, 15.78], p < 0.05,
very low certainty). Naltrexone had no significant effect on smoking
cessation in short-term or long-term observations (three RCTs, OR =
0.99, 95% CI: [0.54, 1.81], p = 0.97, moderate certainty), and
Topiramate had no significant effect (two RCTs, OR = 1.56, 95% CI:
[0.67, 3.46], p > 0.05, low certainty). Only one trial
reported that Bupropion had no effect on smoking cessation. Conclusion
Varenicline may have a positive effect on smoking cessation in people
with alcohol dependence. However, Naltrexone, Topiramate, and Bupropion
seem to have no clear effect on increasing smoking abstinence among
drinkers. The small number of studies and the low certainty of evidence
indicate that caution is required in interpreting the results.
Title: The Effects of Pharmacological Interventions on Smoking Cessation in People with Alcohol Dependence: A Systematic Review and Meta-analysis of Nine Randomized Controlled Trials
Description:
Background Pharmacotherapies are widely used for smoking cessation.
However, their effect on smoking cessation for people with alcohol
dependence remains unclear.
Objective This study aimed to explore the
effects of pharmacotherapies on smoking cessation for people with
alcohol dependence.
Methods Five electronic databases were searched in
January 2021 for randomized controlled trials (RCTs) reporting the use
of pharmacotherapies to promote smoking cessation in people with alcohol
dependence.
The risk of bias was assessed using the Cochrane tool.
RevMan version 5.
3 was used to perform meta-analyses of the changes in
smoking behavior, and the GRADE approach was used to assess the
certainty of the evidence.
Results Nine RCTs involving 908 smokers with
alcohol dependence were identified.
Eight RCTs were published in the
United States, and one was from Canada.
The risk of bias was rated as
low in three studies and unclear in the remaining six.
The results of
the meta-analysis showed that, compared with the placebo group,
Varenicline had a significant effect on short-term smoking cessation
(three RCTs, OR = 6.
27, 95% CI: [2.
49, 15.
78], p < 0.
05,
very low certainty).
Naltrexone had no significant effect on smoking
cessation in short-term or long-term observations (three RCTs, OR =
0.
99, 95% CI: [0.
54, 1.
81], p = 0.
97, moderate certainty), and
Topiramate had no significant effect (two RCTs, OR = 1.
56, 95% CI:
[0.
67, 3.
46], p > 0.
05, low certainty).
Only one trial
reported that Bupropion had no effect on smoking cessation.
Conclusion
Varenicline may have a positive effect on smoking cessation in people
with alcohol dependence.
However, Naltrexone, Topiramate, and Bupropion
seem to have no clear effect on increasing smoking abstinence among
drinkers.
The small number of studies and the low certainty of evidence
indicate that caution is required in interpreting the results.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Varenicline Versus Cytisine for Smoking Cessation in a Primary Care Setting: A Randomized Controlled Trial
Varenicline Versus Cytisine for Smoking Cessation in a Primary Care Setting: A Randomized Controlled Trial
Abstract
Our study aims to implement a smoking cessation program using pharmacotherapy in a real-life setting — primary care practices in Croatia and Slovenia — and...
Problematyka wczesnego alkoholizmu
Problematyka wczesnego alkoholizmu
The Problem of Early Alcoholizm The group of 50 repeatedly convicted recidivists, dealt with in this article, aged 38 on the average, deserves particular attention, first of all ...
Final Report of the Safety Assessment of Alcohol Denat., Including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the Denaturants, Quassin, Brucine Sulfate/Brucine,
Final Report of the Safety Assessment of Alcohol Denat., Including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the Denaturants, Quassin, Brucine Sulfate/Brucine,
Alcohol Denat. is the generic term used by the cosmetics industry to describe denatured alcohol. Alcohol Denat. and various specially denatured (SD) alcohols are used as cosmetic i...
Formerly Smoking and Currently Smoking Cancer Survivors’ View on Smoking Cessation – A Qualitative Study
Formerly Smoking and Currently Smoking Cancer Survivors’ View on Smoking Cessation – A Qualitative Study
Background
Drastic life events, such as a cancer diagnosis, do not necessarily lead to a reduction in unhealthy and dysfunctional behaviors like smoking. Contin...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Evaluating the effect of smoking and its cessation on semen parameters
Evaluating the effect of smoking and its cessation on semen parameters
Our primary aim was to investigate the reversibility of the negative impact of smoking on male fertility. Secondarily, we studied the effect of both time after smoking cessation as...

